IP Library Granted Patent US 8,404,479
Granted Patent B2
US 8,404,479 · App. 12/458,662 · Granted Mar 26, 2013

Simple membrane assay method and kit

Inventors: Hideharu Shimizu (Gosen, JP); Takeshi Watanabe (Gosen, JP); Kazuyuki Takizawa (Gosen, JP); Junji Matsuda (Gosen, JP); Toshinori Sato (Gosen, JP)
Assignee: Denka Seiken Co., Ltd
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,404,479
App. No.
12/458,662
Granted
Mar 26, 2013
Kind
B2
Abstract

A simple membrane assay method for detecting or quantitating an analyte in a specimen sample using an assay device equipped with a membrane bound with a capture-substance to capture the analyte, including the steps of filtering a specimen sample using a filter, dropping the filtrate onto said membrane and detecting the presence of the analyte in said specimen sample, as well as a simple membrane assay kit for detecting the presence of an analyte in a specimen sample, including (1) a filter tube, and (2) an assay device equipped with a membrane bound with a capture-substance to capture the analyte. The method or the kit can decrease the occurrence of false positivity and can provide a highly accurate detection of the analyte such as pathogen and antibody in a specimen collected in a medical scene or by an individual.

Claims (17)

1. A membrane assay method for detecting or quantitating an analyte in a specimen sample using (i) an assay device equipped with a membrane bound with a capture-substance to capture the analyte and (ii) a filter tube consisting of a body part and a tip part, wherein the body part of the filter tube is made of flexible material, wherein the method comprises the steps of:

(i) placing a suspension of specimen in the body part of the filter tube;

(ii) attaching the tip part equipped with a filter to the body part;

(iii) filtering the specimen sample through the filter by applying pressure in the filter tube by hand;

(iv) then dropping the filtrate onto the membrane; and

(v) detecting or quantitating the presence of the analyte in the specimen sample,

wherein a pore size or particle retention size of the membrane is not less than a pore size or particle retention size of the filter.

2. The method according to claim 1 , wherein the specimen sample has been collected from pharynx or nasal cavity of a patient.

3. The method according to claim 1 , wherein the flexible material is selected from the group consisting of polyethylene and polyethylene terephthalate.

4. The method according to claim 1 , wherein the material of the filter is selected from the group consisting of nonwoven fabric, paper, glass fiber, silica fiber, nitrocellulose, cellulose ester, a mixture of nitrocellulose and cellulose ester, polyether sulfone, polysulfone, polyethylene tetrafluoride, polyvinylidene fluoride, polycarbonate, polypropylene, polyamide, 6,6-nylon, polyester, cotton, stainless steel fiber and a combination thereof.

5. The method according to claim 1 , wherein the pore size or the particle retention size of the filter is from 0.2 to 8.0 μm.

6. The method according to claim 1 , wherein the filter is a glass fiber filter, a nitrocellulose filter, or a combination of glass fiber filter and nitrocellulose filter.

7. The method according to claim 1 , wherein the material of the membrane is selected from the group consisting of nonwoven fabric, paper, nitrocellulose, glass fiber, silica fiber, cellulose ester, polyether sulfone, polysulfone, polyethylene tetrafluoride, polyvinylidene fluoride, polycarbonate, polypropylene, polyamide, 6,6-nylon and a mixture of cellulose ester and nitrocellulose, and that the pore size or the particle retention size of the membrane is not less than the pore size or the particle retention size of the filter and is from 0.3 to 15 μm.

8. The method according to claim 7 , wherein the material of the membrane is nitrocellulose and its pore size is from 0.4 to 12 μm.

9. The method according to claim 1 , wherein the analyte is an influenza virus.

10. The method according to claim 1 , which is a flow-through type or lateral-flow type membrane assay method.

11. The flow-through type membrane assay method according to claim 10 , wherein the pore size or the particle retention size of the filter is from 0.2 to 4.0 μm.

Assignments (2)
MERGER Recorded Sep 8, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 054159/0100 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2012
From: SHIMIZU, HIDEHARU; WATANABE, TAKESHI; TAKIZAWA, KAZUYUKI; MATSUDA, JUNJI; SATO, TOSHINORI
To: DENKA SEIKEN CO., LTD
Reel/Frame 028434/0488 →
Continuity (3)
Division 11471622 · Jun 21, 2006
Continuation PCTJP0316615 · Dec 24, 2003
Related Publication 20090286226A1 · Nov 19, 2009